193 related articles for article (PubMed ID: 31196754)
1. In vitro and in silico elucidation of antidiabetic and anti-inflammatory activities of bioactive compounds from Momordica charantia L.
Shivanagoudra SR; Perera WH; Perez JL; Athrey G; Sun Y; Wu CS; Jayaprakasha GK; Patil BS
Bioorg Med Chem; 2019 Jul; 27(14):3097-3109. PubMed ID: 31196754
[TBL] [Abstract][Full Text] [Related]
2. Cucurbitane-type compounds from Momordica charantia: Isolation, in vitro antidiabetic, anti-inflammatory activities and in silico modeling approaches.
Shivanagoudra SR; Perera WH; Perez JL; Athrey G; Sun Y; Jayaprakasha GK; Patil BS
Bioorg Chem; 2019 Jun; 87():31-42. PubMed ID: 30856374
[TBL] [Abstract][Full Text] [Related]
3. Anti-Inflammatory, Antidiabetic Properties and In Silico Modeling of Cucurbitane-Type Triterpene Glycosides from Fruits of an Indian Cultivar of
Perera WH; Shivanagoudra SR; Pérez JL; Kim DM; Sun Y; K Jayaprakasha G; S Patil B
Molecules; 2021 Feb; 26(4):. PubMed ID: 33669312
[TBL] [Abstract][Full Text] [Related]
4. Investigation of Biological Activities of Wild Bitter Melon (
Pham TMH; Ngo DH; Ngo DN; Vo TS
Biomolecules; 2019 May; 9(6):. PubMed ID: 31151277
[TBL] [Abstract][Full Text] [Related]
5. BG-4, a novel bioactive peptide from momordica charantia, inhibits lipopolysaccharide-induced inflammation in THP-1 human macrophages.
Jones LD; Pangloli P; Krishnan HB; Dia VP
Phytomedicine; 2018 Mar; 42():226-232. PubMed ID: 29655690
[TBL] [Abstract][Full Text] [Related]
6. Thermal treatment enhances the α-glucosidase inhibitory activity of bitter melon (Momordica charantia) by increasing the free form of phenolic compounds and the contents of Maillard reaction products.
Hsieh HJ; Lin JA; Chen KT; Cheng KC; Hsieh CW
J Food Sci; 2021 Jul; 86(7):3109-3121. PubMed ID: 34146408
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antidiabetic activity of Taraxacum officinale (L.) Weber ex F.H.Wigg and Momordica charantia L. polyherbal combination.
Perumal N; Nallappan M; Shohaimi S; Kassim NK; Tee TT; Cheah YH
Biomed Pharmacother; 2022 Jan; 145():112401. PubMed ID: 34785415
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory Effects of Cucurbitane-Type Triterpenoids from
Cao TQ; Phong NV; Kim JH; Gao D; Anh HLT; Ngo VD; Vinh LB; Koh YS; Yang SY
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361596
[TBL] [Abstract][Full Text] [Related]
9. EMCD, a hypoglycemic triterpene isolated from Momordica charantia wild variant, attenuates TNF-α-induced inflammation in FL83B cells in an AMP-activated protein kinase-independent manner.
Cheng HL; Kuo CY; Liao YW; Lin CC
Eur J Pharmacol; 2012 Aug; 689(1-3):241-8. PubMed ID: 22683870
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.).
Poovitha S; Parani M
BMC Complement Altern Med; 2016 Jul; 16 Suppl 1(Suppl 1):185. PubMed ID: 27454418
[TBL] [Abstract][Full Text] [Related]
11. Bitter melon: a panacea for inflammation and cancer.
Dandawate PR; Subramaniam D; Padhye SB; Anant S
Chin J Nat Med; 2016 Feb; 14(2):81-100. PubMed ID: 26968675
[TBL] [Abstract][Full Text] [Related]
12. Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-κB and JNK pathways in high-fat-fed OLETF rats.
Yang SJ; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY
J Nutr Biochem; 2015 Mar; 26(3):234-40. PubMed ID: 25488547
[TBL] [Abstract][Full Text] [Related]
13.
Lee SY; Wong WF; Dong J; Cheng KK
Molecules; 2020 Aug; 25(17):. PubMed ID: 32825228
[TBL] [Abstract][Full Text] [Related]
14. Momordica charantia Inhibits Inflammatory Responses in Murine Macrophages via Suppression of TAK1.
Yang WS; Yang E; Kim MJ; Jeong D; Yoon DH; Sung GH; Lee S; Yoo BC; Yeo SG; Cho JY
Am J Chin Med; 2018; 46(2):435-452. PubMed ID: 29463104
[TBL] [Abstract][Full Text] [Related]
15. Bitter melon fruit extract has a hypoglycemic effect and reduces hepatic lipid accumulation in ob/ob mice.
Dwijayanti DR; Shimada T; Ishii T; Okuyama T; Ikeya Y; Mukai E; Nishizawa M
Phytother Res; 2020 Jun; 34(6):1338-1346. PubMed ID: 31845444
[TBL] [Abstract][Full Text] [Related]
16. Suppressive effects of wild bitter gourd (Momordica charantia Linn. var. abbreviata ser.) fruit extracts on inflammatory responses in RAW264.7 macrophages.
Lii CK; Chen HW; Yun WT; Liu KL
J Ethnopharmacol; 2009 Mar; 122(2):227-33. PubMed ID: 19330915
[TBL] [Abstract][Full Text] [Related]
17. Metabolite profiling and in vitro biological activities of two commercial bitter melon (Momordica charantia Linn.) cultivars.
Perez JL; Jayaprakasha GK; Patil BS
Food Chem; 2019 Aug; 288():178-186. PubMed ID: 30902279
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effect of Momordica charantia in sepsis mice.
Chao CY; Sung PJ; Wang WH; Kuo YH
Molecules; 2014 Aug; 19(8):12777-88. PubMed ID: 25153878
[TBL] [Abstract][Full Text] [Related]
19. Cucurbitane-type triterpenoids from the vines of Momordica charantia and their anti-inflammatory, cytotoxic, and antidiabetic activity.
Liaw CC; Huang HT; Liu HK; Lin YC; Zhang LJ; Wei WC; Shen CC; Wu CL; Huang CY; Kuo YH
Phytochemistry; 2022 Mar; 195():113026. PubMed ID: 34890886
[TBL] [Abstract][Full Text] [Related]
20. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.
Kim SK; Jung J; Jung JH; Yoon N; Kang SS; Roh GS; Hahm JR
Complement Ther Med; 2020 Aug; 52():102524. PubMed ID: 32951763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
